مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.
Normal view MARC view ISBD view

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. [electronic resource]

By:
  • Burkhardt, Lia
Contributor(s):
  • Fuchs, Sarah
  • Krohn, Antje
  • Masser, Sawinee
  • Mader, Malte
  • Kluth, Martina
  • Bachmann, Frederik
  • Huland, Hartwig
  • Steuber, Thomas
  • Graefen, Markus
  • Schlomm, Thorsten
  • Minner, Sarah
  • Sauter, Guido
  • Sirma, Hüseyin
  • Simon, Ronald
Producer: 20130624Description: 2795-805 p. digitalISSN:
  • 1538-7445
Subject(s):
  • Cell Line, Tumor
  • Chromosomes, Human, Pair 5
  • DNA Helicases -- genetics
  • DNA-Binding Proteins -- genetics
  • Gene Deletion
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Gene Rearrangement
  • Genes, Tumor Suppressor
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Oligonucleotide Array Sequence Analysis
  • Polymorphism, Single Nucleotide
  • Prostate-Specific Antigen -- metabolism
  • Prostatic Neoplasms -- genetics
  • Receptors, Androgen -- metabolism
  • Trans-Activators -- metabolism
  • Transcriptional Regulator ERG
  • Translocation, Genetic
Online resources:
  • Available from publisher's website
In: Cancer research vol. 73
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

APA

Burkhardt L., Fuchs S., Krohn A., Masser S., Mader M., Kluth M., Bachmann F., Huland H., Steuber T., Graefen M., Schlomm T., Minner S., Sauter G., Sirma H. & Simon R. (20130624). CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. : Cancer research.

Chicago

Burkhardt Lia, Fuchs Sarah, Krohn Antje, Masser Sawinee, Mader Malte, Kluth Martina, Bachmann Frederik, Huland Hartwig, Steuber Thomas, Graefen Markus, Schlomm Thorsten, Minner Sarah, Sauter Guido, Sirma Hüseyin and Simon Ronald. 20130624. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. : Cancer research.

Harvard

Burkhardt L., Fuchs S., Krohn A., Masser S., Mader M., Kluth M., Bachmann F., Huland H., Steuber T., Graefen M., Schlomm T., Minner S., Sauter G., Sirma H. and Simon R. (20130624). CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. : Cancer research.

MLA

Burkhardt Lia, Fuchs Sarah, Krohn Antje, Masser Sawinee, Mader Malte, Kluth Martina, Bachmann Frederik, Huland Hartwig, Steuber Thomas, Graefen Markus, Schlomm Thorsten, Minner Sarah, Sauter Guido, Sirma Hüseyin and Simon Ronald. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. : Cancer research. 20130624.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site